Cancer Hospitals Often Mark Up Drug Prices, Ignore Price Transparency Rules

Most National Cancer Institute (NCI)–designated cancer centers fail to publicly disclose negotiated prices for cancer therapies, despite federal requirements to do so.

Continue reading here.